
BioNTech SE (NASDAQ:BNTX) shares are trading higher Monday after the company reported financial results and reaffirmed its 2022 outlook.
BioNTech reported first-quarter revenue of 6.37 billion euros ($6.72 billion), which was up from €2.05 billion year-over-year. The company reported quarterly earnings of €14.24 per share, up from earnings of €4.39 per share, year-over-year.